Stimuli‐responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy

Abstract

SummaryImmunogenic cell death (ICD) is a special pattern of tumor cell death, enabling to elicit tumor‐specific immune response via the release of damage‐associated molecular patterns and tumor‐associated antigens in the tumor microenvironment. ICD‐induced immunotherapy holds the promise for completely eliminating tumors and long‐term protective antitumor immune response. Increasing ICD inducers have been discovered for boosting antitumor immunity via evoking ICD. Nonetheless, the utilization of ICD inducers remains insufficient owing to serious toxic reactions, low localization efficiency within the tumor microenvironmental niche, etc. For overcoming such limitations, stimuli‐responsive multifunctional nanoparticles or nanocomposites with ICD inducers have been developed for improving immunotherapeutic efficiency via lowering toxicity, which represent a prospective scheme for fostering the utilization of ICD inducers in immunotherapy. This review outlines the advances in near‐infrared (NIR)‐, pH‐, redox‐, pH‐ and redox‐, or NIR‐ and tumor microenvironment‐responsive nanodelivery systems for ICD induction. Furthermore, we discuss their clinical translational potential. The progress of stimuli‐responsive nanoparticles in clinical settings depends upon the development of biologically safer drugs tailored to patient needs. Moreover, an in‐depth comprehending of ICD biomarkers, immunosuppressive microenvironment, and ICD inducers may accelerate the advance in smarter multifunctional nanodelivery systems to further amplify ICD.